08:30 - 08:45 Opening ceremony
- A Almeida - President EHA
- JF Comenalli Marques Jr - President ABHH
- C Chiattone - President HEMO 2023
08:45 - 10:15 Session 1: Non-malignant hematology
Chairs: TBC
- How to personalize the first-line therapy in Follicular Lymphoma
E Kimby (Sweden)
- Inherited red cell enzymopathies
L Luzzatto (Tanzania)
- Platelets and inflammation
K Martinod (Belgium)
10:15 - 11:15 Scientific Works with guided works
11:15 - 11:30 Coffee break
11:30 - 13:00 Session 2: State of the Art: Gene therapy, tumor tracking and personalised medicine
Chairs: E Kimby (Sweden) & TBC
- How to approach relapsed follicular lymphoma
M Ladetto (Italy)
- Using ctDNA to track behaviour of aggressive high-risk B-cell lymphomas
S Leppä (Finland)
- R Rosenquist (Sweden)
Development of genetic panels across lymphoid malignancies - a path to clinical implementation?
13:00 - 13:30 Lunch break
13:30 - 14:30 Corporate symposia
14:30 - 15:00 Coffee break
15:00 - 16:30 Session 3: Clonal hematopoiesis and myeloid malignancies
Chairs: TBC
- Clonal hematopoiesis – Causes and consequences
K Grønbæk (Denmark)
- Mast cells in health and disease
O Hermine (France)
- How I diagnosis and prognosticate in CMML
J Ungerstedt (Sweden)
16:30 - 17:00 Coffee break
17:00 - 18:15 Regional Symposium: Drug & Treatment Access
Chairs: D McLornan (United Kingdom) & TBC
- Status in Europe
A Almeida (Portugal)
- AML
E Rego (Brazil) - Chair
Panelists to be announced
- Multiple myeloma
A Maiolino (Brazil) - Chair
Panelists to be announced
18:15 - 18:30 Closing ceremony
Back